Want to see IN:YATHARTH full AI Analyst Report?
Top Page
Yatharth Hospital and Trauma Care Services Limited
(YATHARTH)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹1,135.00
▲(62.19% Upside)
Action:Reiterated
Date:09/18/26
The score is driven primarily by solid operating performance and improved leverage, but is capped by persistently negative free cash flow and a high P/E valuation. Technicals are supportive, with a strong uptrend and positive momentum.
Positive Factors
Strong Revenue Growth
Strong and sustained revenue expansion indicates that the hospital network is broadening its patient and service base. Continued top-line growth can improve utilization of clinical infrastructure, support operating scale, and provide a durable foundation for earnings growth over the coming quarters.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow means reported earnings are not yet translating into cash available after investment. Heavy reinvestment or working-capital swings can limit self-funded growth, increase reliance on financing, and reduce flexibility if operating conditions weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Strong and sustained revenue expansion indicates that the hospital network is broadening its patient and service base. Continued top-line growth can improve utilization of clinical infrastructure, support operating scale, and provide a durable foundation for earnings growth over the coming quarters.
Read all positive factors
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹94.70B
Dividend Yield0.05%
Average Volume (3M)22.85K
Price to Earnings (P/E)57.0
Beta (1Y)1.26
Revenue Growth44.00%
EPS Growth24.10%
CountryIN
Employees7,440
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)18.80
Shares Outstanding96,354,355
10 Day Avg. Volume18,351
30 Day Avg. Volume22,851
Financial Highlights & Ratios
PEG Ratio1.43
Price to Book (P/B)3.34
Price to Sales (P/S)4.93
P/FCF Ratio-62.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.66
Revenue Forecast (FY)₹17.08B
Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model
Company Description
Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare...
How the Company Makes Money
YATHARTH primarily makes money by delivering healthcare services to patients through its hospitals. Key revenue streams typically include: (1) Inpatient services: charges for hospital bed occupancy, nursing care, ICU/critical care, operation theat...
Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
71
Positive
Cash Flow
42
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.34B | 12.07B | 8.80B | 6.71B | 5.20B | 4.01B |
| Gross Profit | 7.90B | 6.50B | 5.39B | 5.37B | 4.27B | 3.20B |
| EBITDA | 3.35B | 2.92B | 2.36B | 1.96B | 1.37B | 1.13B |
| Net Income | 1.81B | 1.75B | 1.31B | 1.14B | 657.68M | 441.62M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 22.82B | 17.31B | 10.19B | 4.86B | 4.26B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 2.98B | 5.15B | 2.39B | 382.36M | 120.31M |
| Total Debt | 0.00 | 2.64B | 115.86M | 846.47M | 2.67B | 2.64B |
| Total Liabilities | -18.07B | 4.74B | 940.45M | 1.45B | 3.03B | 3.09B |
| Stockholders Equity | 18.07B | 17.81B | 16.05B | 8.74B | 1.83B | 1.17B |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -956.83M | -1.61B | -964.43M | 439.70M | 468.01M |
| Operating Cash Flow | 485.14M | 2.21B | 1.50B | -30.78M | 637.84M | 599.35M |
| Investing Cash Flow | -2.51B | -6.17B | -4.20B | -2.26B | -203.10M | -521.75M |
| Financing Cash Flow | 142.57M | 2.56B | 5.19B | 3.04B | -177.48M | -11.24M |
Yatharth Hospital and Trauma Care Services Limited Technical Analysis
Positive
699.80
Price Trends
899.76
Positive
864.71
Positive
769.60
Positive
Market Momentum
44.99
Negative
79.16
Negative
70.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 699.8 is below the 20-day moving average (MA) of 977.97, below the 50-day MA of 899.76, and below the 200-day MA of 769.60, indicating a bullish trend. The MACD of 44.99 indicates Negative momentum. The RSI at 79.16 is Negative, neither overbought nor oversold. The STOCH value of 70.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.
Yatharth Hospital and Trauma Care Services Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹51.63B | 43.44 | ― | 0.14% | 14.96% | 20.76% | |
62 Neutral | ₹94.70B | 57.04 | ― | 0.05% | 44.00% | 24.10% | |
62 Neutral | ₹378.45B | 46.07 | ― | 0.24% | 57.80% | 4.07% | |
60 Neutral | ₹655.68B | 63.84 | ― | 0.11% | 17.50% | 20.65% | |
59 Neutral | ₹1.25T | 60.33 | ― | 0.23% | 17.20% | 32.79% | |
55 Neutral | ₹1.01T | 69.27 | ― | 0.19% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
1,140.75
365.01
47.05%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,770.25
981.73
12.60%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
338.45
100.50
42.24%
IN:FORTIS
Fortis Healthcare Ltd.
875.00
-78.64
-8.25%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,055.00
-103.79
-8.96%
IN:NH
Narayana Hrudayalaya Ltd.
1,929.75
155.69
8.78%
Yatharth Hospital and Trauma Care Services Limited Corporate Events
Yatharth Hospital boosts authorised capital and secures major minority investment
Sep 17, 2026
Yatharth Hospital Trauma Care Services Limited’s board has approved an increase in authorised share capital from INR 115 crore to INR 150 crore, subject to shareholder and regulatory approvals, requiring an amendment to its Memorandum of As...
Yatharth Hospital Challenges Large Tax Demands After Final Assessments
Sep 14, 2026
Yatharth Hospital and its subsidiaries AKS Medical Research Centre and Ramraja Multispeciality Hospital have received final income tax assessment orders from the Delhi tax authorities, raising aggregate demands of over Rs. 43 crores in tax and ab...
Yatharth Hospital Files FY 2025-26 Business Responsibility and Sustainability Report
Sep 3, 2026
Yatharth Hospital and Trauma Care Services Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 to the National Stock Exchange of India and BSE Limited in compliance with SEBI disclosure regula...
Yatharth Hospital to Join Nuvama India 2026 Investor Conference via Virtual Meet
Aug 8, 2026
Yatharth Hospital and Trauma Care Services has announced that its management will participate in the Nuvama India Conference 2026 (Singapore Edition) on August 12, 2026, via a virtual investor meeting. The company emphasized that no unpublished pr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.